Technical Analysis for CTOR - Citius Oncology, Inc.

Grade Last Price % Change Price Change
F 1.14 -3.80% -0.05
CTOR closed down 3.8 percent on Friday, November 1, 2024, on 24 percent of normal volume.
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down

Date Alert Name Type % Chg
Narrow Range Bar Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Down 3 Days in a Row Weakness 0.00%
Narrow Range Bar Range Contraction -3.80%
Inside Day Range Contraction -3.80%
Wide Bands Range Expansion -3.80%
Narrow Range Bar Range Contraction -5.79%
Wide Bands Range Expansion -5.79%
Narrow Range Bar Range Contraction -6.13%
Wide Bands Range Expansion -6.13%

   Recent Intraday Alerts

Alert Time
Fell Below Previous Day's Low about 23 hours ago
Down 2 % 1 day ago
Down 1% 1 day ago
Up 2% 1 day ago
Up 1% 1 day ago

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Citius Oncology will serve as a platform to develop and commercialize novel targeted oncology therapies. In August 2024, its primary asset, LYMPHIR, was approved by the FDA for the treatment of adults with relapsed or refractory CTCL who had had at least one prior systemic therapy. Management estimates the initial market for LYMPHIR currently exceeds $400 million, is growing, and is underserved by existing therapies. Robust intellectual property protections that span orphan drug designation, complex technology, trade secrets and pending patents for immuno-oncology use as a combination therapy with checkpoint inhibitors would further support Citius Oncology's competitive positioning. Citius Oncology is a publicly traded subsidiary of Citius Pharmaceuticals.
Classification

Keywords: FDA Oncology Therapies

Is CTOR a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 49.0
52 Week Low 0.932
Average Volume 136,212
200-Day Moving Average 8.75
50-Day Moving Average 1.43
20-Day Moving Average 1.13
10-Day Moving Average 1.21
Average True Range 0.24
RSI (14) 40.12
ADX 5.49
+DI 23.87
-DI 23.89
Chandelier Exit (Long, 3 ATRs) 0.68
Chandelier Exit (Short, 3 ATRs) 1.65
Upper Bollinger Bands 1.33
Lower Bollinger Band 0.93
Percent B (%b) 0.53
BandWidth 35.72
MACD Line -0.23
MACD Signal Line -0.33
MACD Histogram 0.1033
Fundamentals Value
Market Cap 10.19 Million
Num Shares 8.94 Million
EPS 0.20
Price-to-Earnings (P/E) Ratio 5.70
Price-to-Sales 0.00
Price-to-Book 1.41
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.25
Resistance 3 (R3) 1.26 1.23 1.23
Resistance 2 (R2) 1.23 1.21 1.23 1.22
Resistance 1 (R1) 1.19 1.19 1.18 1.18 1.22
Pivot Point 1.16 1.16 1.16 1.16 1.16
Support 1 (S1) 1.12 1.14 1.11 1.11 1.06
Support 2 (S2) 1.09 1.12 1.09 1.06
Support 3 (S3) 1.05 1.09 1.05
Support 4 (S4) 1.04